Post-stent chest pain, revisited
Heart Sisters
JULY 28, 2024
Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Heart Sisters
JULY 28, 2024
Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.
Medical Xpress - Cardiology
FEBRUARY 21, 2024
Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) in heart disease patients significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI alone, the most commonly used method.
Dr. Paddy Barrett
NOVEMBER 28, 2023
One of the most common questions I get is, “ Do I need a stent to treat my heart disease?” ” Typically, several of this person’s friends have had stents, so it seems natural to ask. First, we must understand what a stent is and why it is used. The stent ‘unblocks’ it.
Science Daily - Heart Disease
APRIL 8, 2024
New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures.
Frontiers in Cardiovascular Medicine
JANUARY 10, 2024
Coronary heart disease is a narrowing or obstruction of the vascular cavity caused by atherosclerosis of the coronary arteries, which leads to myocardial ischemia and hypoxia. At present, percutaneous coronary intervention (PCI) is an effective treatment for coronary atherosclerotic heart disease.
Frontiers in Cardiovascular Medicine
JULY 25, 2024
The past five years have yielded impressive advancements in fully absorbable metal stent technology. Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD).
AMS Cardiology
OCTOBER 11, 2024
Heart disease remains a leading cause of death worldwide despite advancements in medical science and healthcare. Below, we aim to debunk common myths about cardiovascular disease, providing accurate information and emphasizing the importance of treatment for heart disease with timely interventions.
Open Heart
JANUARY 11, 2023
Objectives To evaluate bare-metal Optimus and polytetrafluoroethylene (PTFE)-covered Optimus-CVS balloon-expandable, cobalt–chromium, hybrid cell–designed stents in congenital heart disease (CHD) interventions. Methods Retrospective multicentre review of patients with CHD receiving Optimus stents. mm (IQR, 15.2–22)
Med Page Today
APRIL 30, 2024
(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.
Journal of Cardiovascular Electrophysiology
FEBRUARY 8, 2024
Abstract Introduction Management of transvenous leads in patients with congenital heart disease (CHD) can be complicated by venous obstructions and residual shunts. We present our experience performing concurrent lead extraction and dilation/stenting of venous pathways, including patients with complete venous obstruction.
DAIC
MAY 3, 2024
Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease 6. Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9. Novel CT Exam Reduces Need for Invasive Artery Treatment 7. FDA Announces Recalls of Abbott/Thoratec Corp.
DAIC
JUNE 18, 2024
The breakthrough designation, according to the Milpitas, CA-based technology company, is for an indication to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. of the U.S.
Journal of Cardiovascular Pharmacology
NOVEMBER 26, 2023
Abstract: The mechanism of in-stent restenosis (ISR) remains elusive, and in-stent neoatherosclerosis (ISNA) may hold siginificant pathophysiological implications. This study enrolled 225 patients diagnosed with coronary heart disease and multivessel disease (MVD).
Dr. Smith's ECG Blog
JANUARY 31, 2020
Angiogram: Widely patent RCA and LAD stents. Therefore, no stent was placed. (No It is proven better than angiography alone in stable angina , and also has been shown to improve decisions on stenting non-culprit lesions in ACS. We are told that this middle-aged male patient has a history of prior MI with stents.
DAIC
MAY 7, 2024
narrates and is a co-producer of a documentary focused on radiation and orthopedic injuries suffered by doctors and nurses who work in cardiac catheterization laboratories where they apply the very latest non-surgical technologies to treat the world’s leading cause of death, heart disease. Rizik , M.D.,
DAIC
FEBRUARY 24, 2025
Meanwhile, traditional methods for cardiac detection still rely on reactive, symptom-driven interventions that often catch heart disease too late, when treatment is complex, critical and costly. AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions.
Frontiers in Cardiovascular Medicine
JULY 5, 2024
IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications.
Frontiers in Cardiovascular Medicine
JANUARY 10, 2024
Herein, we compare conventional biplane angiography to multimodality image fusion with live fluoroscopy using two-dimensional (2D)–three-dimensional (3D) registration (MMIF 2D−3D ) and assess MMIF 2D−3D impact on radiation exposure and contrast volume during cardiac catheterization of patients with congenital heart disease (CHD).
AMS Cardiology
SEPTEMBER 30, 2024
Heart disease is a leading cause of death worldwide. At AMS Cardiology, we believe proactive care is essential for maintaining optimal heart health. Below we’ll discuss the importance of heart screenings , check-ups and cardiac disease prevention and why choosing AMS Cardiology for your care is the right decision.
Dr. Prateek Bhatnagar
OCTOBER 27, 2020
He himself developed heart disease a couple of years later. He next underwent stenting in his coronary arteries in 2000, 2010 and 2012 at Pune. A total of 6 stents were placed. Coronary angiography showed multiple blocks in the stents, needing an urgent bypass surgery. He recently developed unstable angina.
All About Cardiovascular System and Disorders
FEBRUARY 17, 2024
It can provide intraluminal fly-through and clipping-plane views which help endovascular assessment of stents, aneurysms, vessel wall irregularities and calcification. The dataset could even be used to generate 3D-printed models of congenital heart disease [2]. Reference Kang SL, Armstrong A, Krings G, Benson L.
MIBHS
SEPTEMBER 15, 2024
Heart disease is often perceived as a predominantly male issue, but the reality tells a different story. This blog post aims to shed light on the unique considerations and risks associated with heart health in women, empowering them with the knowledge to take proactive steps in protecting their hearts.
Dr. Smith's ECG Blog
SEPTEMBER 19, 2023
Past medical history includes coronary stenting 17 years prior. If you take old people with a history of MI (he had a stent), that percentage goes far higher since there is scar tissue that acts as a nidus for the PVCs that initiate VT. He had concurrent sharp substernal chest pain that resolved, but palpitations continued.
Physiologically Speaking
JANUARY 5, 2024
In this 6-month randomized controlled study, twice-weekly HIIT reduced coronary plaque volume, increased aerobic fitness, and improved body composition in adults with stable heart disease, suggesting benefits for cardiovascular disease progression. Among the participants were 54 men and 5 women with an average age of 58.
DAIC
MAY 14, 2024
Within the complex umbrella of cardiovascular disease, CAD is a type of heart disease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.
DAIC
DECEMBER 14, 2023
“The National Cardiogenic Shock Initiative is the largest prospective study of therapy for severe heart attack cardiogenic shock done in the United States in the past two decades,” said William O’Neill, M.D. medical director emeritus of Henry Ford’s Center for Structural Heart Disease and principal investigator of the study.
DAIC
APRIL 6, 2024
The study’s primary endpoint was the time to the first occurrence of a major adverse cardiovascular event (MACE; i.e., heart attack, stroke or death due to heart disease or a stroke) at 90 days. In an exploratory analysis, however, patients treated with CSL112 were 14% less likely to have or die from a heart attack at 180 days.
Cardiology Update
JANUARY 7, 2024
Fellows 2024 offers hands-on training covering revascularization, angioplasty, stents, pharmacologic therapy, and intravascular imaging/physiology. Noncoronary topics like structural heart disease and vascular medicine are also addressed. The course is relevant for the entire heart valve team.
DAIC
JUNE 28, 2024
Heart disease is the leading killer annually — about 18 million deaths per year — and that number is growing. With calcification in blood vessels, a stent can help, but you can’t do that with the aortic valve. A large proportion is the result of calcification,” said study leader Bruce Fouke , a U.
Frontiers in Cardiovascular Medicine
JANUARY 30, 2024
Background Axillary arterial access (AAA) in pediatric heart catheterizations is undervalued. Methods We retrospectively reviewed children with congenital heart diseases (CHDs) who received trans-axillary arterial catheterizations between January 2019 and February 2023. Results We identified 30 patients (66.7% months (IQR, 0.3–5.4),
All About Cardiovascular System and Disorders
JANUARY 14, 2024
Right Heart Catheterization in Tetralogy of Fallot With the availability of high resolution echocardiographic images and Doppler echocardiography, role of cardiac catheterization has come down in tetralogy of Fallot and other congenital heart diseases in general. References Wagdy R. Arch Med Sci Atheroscler Dis. 2018.76824.
DAIC
APRIL 6, 2024
The study’s primary endpoint was the time to the first occurrence of a major adverse cardiovascular event (MACE; i.e., heart attack, stroke or death due to heart disease or a stroke) at 90 days. In an exploratory analysis, however, patients treated with CSL112 were 14% less likely to have or die from a heart attack at 180 days.
DAIC
APRIL 5, 2024
IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heart attack. IVL helps restore blood flow by cracking calcium lesions using sonic pressure waves and is used in both CAD and PAD, often in combination with stenting.
Circulation
NOVEMBER 11, 2024
Introduction:Dextrocardia is a rare congenital condition where the heart's apex points to the right, with an incidence of about 0.01%. Patients usually have a normal life expectancy unless other structural heart diseases are present. An intravascular ultrasound was also performed, which was negative for vessel dissection.
Dr. Smith's ECG Blog
JUNE 11, 2024
Sent by anonymous A man in his 40s with no previous heart disease presented within 30 minutes of onset of acute chest pain that started while exercising. Successful drug-eluting stent placement opening up 95% mid RCA stenosis to 0% residual Nonobstructive left system disease. Written by Pendell Meyers with edits by Smith.
The British Journal of Cardiology
AUGUST 1, 2024
Large-scale observational data have demonstrated a robust, independent association of elevated lipoprotein(a) (Lp[a]) levels with atherosclerotic cardiovascular disease (CVD), stroke, and peripheral artery disease.
Dr. Smith's ECG Blog
JULY 3, 2018
Submitted and written by Alex Bracey with edits by Pendell Meyers and Steve Smith Case A 50ish year old man with a history of CAD w/ prior LAD MI s/p LAD stenting presented to the ED with chest pain similar to his prior MI, but worse. The patient underwent successful placement of one drug eluting stent with restoration of TIMI 3 flow.
Dr. Smith's ECG Blog
JANUARY 16, 2020
It was opened and stented with resulting TIMI-3 (normal) flow. The stent to LCX is patent. With all of this evidence of severe preexisting heart disease — it can be very challenging to look at an initial ECG ( when no prior tracing is available ) to determine, What is New vs Old? OM1 is occluded and OM2 has 60% stenosis.
Heart Sisters
AUGUST 18, 2024
Personal tips from an experienced open heart surgery patient to help you in the hospital, when you’re going back home, and long afterwards.
Dr. Anish Koka
JULY 15, 2023
Heartflow is a California based company that claims to be able to identify heart vessels leading to a lack of blood to the heart muscle that need coronary stents to fix. I’ve written a number of times about the scourge of heart disease in men. Does Brad need a Heartflow scan?
Dr. Anish Koka
MAY 16, 2023
The CDC wonder database that tracks mortality data shows just how much more deadly heart disease is in men than women. The table below shows mortality from heart disease for men vs women in 2000. Men die of heart disease at more than two times the rate women die starting at the age of 35.
Dr. Smith's ECG Blog
JANUARY 9, 2024
The patient is female in her 80s with a medical hx of previous MI with PCI and stent placement. This figure goes up to ~90% Pre-Test Likelihood — IF the patient is "older" ( ie, an adult of a "certain" age ) — and if the patient has underlying heart disease. The last echocardiography 12 months ago showed HFmrEF.
EMS 12-Lead
APRIL 2, 2022
He reported a history of ischemic cardiomyopathy with coronary stent placement approximately 10 years prior, but could not recall the specific artery involved. Furthermore, V5 and V6 display rS patterns to suggest a delayed transitional zone directed leftward as the result of cardiac dilation in the presence of ischemic heart disease.
Dr. Sanjay Gupta
MARCH 6, 2022
So virtually all the tests that we do on the heart are driven by the need to know more about the pumping ability of the heart, the heart arteries and the electrics of the heart. If the heart has been left damaged, then that part of. An echo is easy to do, risk free and easily accessible.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content